妊娠期糖尿病血糖控制轨迹与围产期并发症风险
该基于人群的队列研究纳入2007年1月至2017年12月在Kaiser Permanente Northern California接受远程医疗妊娠期糖尿病管理项目的26774例妊娠期糖尿病个体,基于美国糖尿病协会推荐的自测血糖数据用潜类别模型识别出4种血糖控制轨迹。以快速改善至最佳轨迹为参照,稳定最佳轨迹者剖宫产、肩难产、大于胎龄儿和新生儿ICU入住风险更低,而缓慢改善至次优轨迹者上述风险更高,且趋势检验P<.001。稳定最佳组小于胎龄儿风险更高,缓慢改善至次优组则更低。作者认为未来干预应帮助个体在诊断后早期及整个孕期实现血糖控制以降低围产期并发症风险。
要点
- 4种血糖控制轨迹:稳定最佳10528例(39.3%)、快速改善至最佳9151例(34.2%)、缓慢改善至接近最佳4161例(15.5%)、缓慢改善至次优2934例(11.0%)。
- 以快速改善至最佳为参照,缓慢改善至次优轨迹者剖宫产aRR 1.18(95%CI 1.12-1.24)、肩难产aRR 1.41(95%CI 1.12-1.78)、大于胎龄儿aRR 1.42(95%CI 1.31-1.53)、新生儿ICU入住aRR 1.33(95%CI 1.20-1.47),趋势检验P<.001。
- 稳定最佳轨迹者剖宫产aRR 0.93(95%CI 0.89-0.96)、肩难产aRR 0.75(95%CI 0.61-0.92)、大于胎龄儿aRR 0.74(95%CI 0.69-0.80)、新生儿ICU入住aRR 0.90(95%CI 0.83-0.97)。
- 小于胎龄儿风险在稳定最佳组更高(aRR 1.10,95%CI 1.02-1.20),在缓慢改善至次优组更低(aRR 0.63,95%CI 0.53-0.75)。
- 作者建议未来干预应帮助个体在妊娠期糖尿病诊断后早期及整个孕期实现血糖控制,以降低围产期并发症风险。
适用人群与场景
- 2007年1月至2017年12月在Kaiser Permanente Northern California接受产前保健并加入其远程医疗妊娠期糖尿病管理项目的妊娠期糖尿病个体,具备从孕前至分娩的纵向电子健康记录数据。
诊断标准与关键阈值
- 最佳血糖控制定义为所有测量中至少80%达到KPNC临床环境下的目标值。
- 血糖控制轨迹基于美国糖尿病协会推荐的自测血糖测量,采用潜类别模型推导。
研究设计与关键结果
- 研究类型:基于人群的队列研究;样本量26774例;平均(SD)年龄32.9(5.0)岁;亚裔或太平洋岛民11196例(41.8%)、黑人1083例(4.0%)、西班牙裔7500例(28.0%)、白人6049例(22.6%)。
- 识别出4种血糖控制轨迹:稳定最佳10528例(39.3%)、快速改善至最佳9151例(34.2%)、缓慢改善至接近最佳4161例(15.5%)、缓慢改善至次优2934例(11.0%)。
- 以快速改善至最佳轨迹组为参照,稳定最佳轨迹组:剖宫产aRR 0.93(95%CI 0.89-0.96)、肩难产aRR 0.75(95%CI 0.61-0.92)、大于胎龄儿aRR 0.74(95%CI 0.69-0.80)、新生儿ICU入住aRR 0.90(95%CI 0.83-0.97)。
- 以快速改善至最佳轨迹组为参照,缓慢改善至次优轨迹组:剖宫产aRR 1.18(95%CI 1.12-1.24;趋势检验P<.001)、肩难产aRR 1.41(95%CI 1.12-1.78;趋势检验P<.001)、大于胎龄儿aRR 1.42(95%CI 1.31-1.53;趋势检验P<.001)、新生儿ICU入住aRR 1.33(95%CI 1.20-1.47;趋势检验P<.001)。
- 小于胎龄儿风险在稳定最佳组更高(aRR 1.10,95%CI 1.02-1.20),在缓慢改善至次优组更低(aRR 0.63,95%CI 0.53-0.75)。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来干预应帮助个体在妊娠期糖尿病诊断后早期及整个孕期实现血糖控制,以降低围产期并发症风险。
- 研究显示缓慢改善至接近最佳和缓慢改善至次优血糖控制轨迹与围产期并发症风险增加相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Glycemic control is the cornerstone of gestational diabetes management. Glycemic control trajectories account for differences in longitudinal patterns throughout pregnancy; however, studies on glycemic control trajectories are scarce.
OBJECTIVE: To examine whether glycemic control trajectories from gestational diabetes diagnosis to delivery were associated with differential risk of perinatal complications.
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included individuals with gestational diabetes with longitudinal electronic health record data from preconception to delivery who received prenatal care at Kaiser Permanente Northern California (KPNC) and were enrolled in KPNC's telemedicine-based gestational diabetes care program between January 2007 and December 2017. Data analysis was conducted from September 2021 to January 2022.
EXPOSURES: Glycemic control trajectories were derived using latent class modeling based on the American Diabetes Association's recommended self-monitoring of blood glucose measurements. Optimal glycemic control was defined as at least 80% of all measurements meeting the targets at KPNC clinical settings.
MAIN OUTCOMES AND MEASURES: Multivariable Poisson regression models were used to estimate the associations of glycemic control trajectories with cesarean delivery, preterm birth, shoulder dystocia, large- and small-for-gestational-age, and neonatal intensive care unit admission and stay of 7 days or longer.
RESULTS: Among a total of 26 774 individuals (mean [SD] age, 32.9 [5.0] years; 11 196 Asian or Pacific Islander individuals [41.8%], 1083 Black individuals [4.0%], 7500 Hispanic individuals [28.0%], and 6049 White individuals [22.6%]), 4 glycemic control trajectories were identified: stably optimal (10 528 individuals [39.3%]), rapidly improving to optimal (9151 individuals [34.2%]), slowly improving to near-optimal (4161 individuals [15.5%]), and slowly improving to suboptimal (2934 individuals [11.0%]). In multivariable models with the rapidly improving to optimal trajectory group as the reference group, glycemic control trajectories were associated with perinatal complications with a gradient across stably optimal to slowly improving to suboptimal. For individuals in the stably optimal trajectory group, there were lower risks of cesarean delivery (adjusted relative risk [aRR], 0.93 [95% CI, 0.89-0.96]), shoulder dystocia (aRR, 0.75 [95% CI, 0.61-0.92]), large-for-gestational age (aRR, 0.74 [95% CI, 0.69-0.80]), and neonatal intensive care unit admission (aRR, 0.90 [95% CI, 0.83-0.97]), while for patients in the slowly improving to suboptimal glycemic control trajectory group, risks were higher for cesarean delivery (aRR, 1.18 [95% CI, 1.12-1.24]; (P for trend < .001), shoulder dystocia (aRR, 1.41 [95% CI, 1.12-1.78]; P for trend < .001), large-for-gestational-age (aRR, 1.42 [95% CI, 1.31-1.53]; P for trend < .001), and neonatal intensive care unit admission (aRR, 1.33 [95% CI, 1.20-1.47]; P for trend < .001). The risk of small-for-gestational-age was higher in patients in the stably optimal group (aRR, 1.10 [95% CI, 1.02-1.20]) and lower in the slowly improving to suboptimal group (aRR, 0.63 [95% CI, 0.53-0.75]).
CONCLUSIONS AND RELEVANCE: These findings suggest that slowly improving to near-optimal and slowly improving to suboptimal glycemic control trajectories were associated with increased risk of perinatal complications. Future interventions should help individuals achieve glycemic control early after gestational diabetes diagnosis and throughout pregnancy to decrease the risk of perinatal complications.
参考来源
- Chehab RF, Ferrara A, Greenberg MB, et al. Glycemic Control Trajectories and Risk of Perinatal Complications Among Individuals With Gestational Diabetes. JAMA Netw Open. 2022. PMID: 36173631. doi:10.1001/jamanetworkopen.2022.33955
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。